Skip to content

Announcements - Search results

Search results: Company announcements for
IMMURON LIMITED (IMC)
Released between 01/01/2016 and 31/12/2016

Didn't find the announcement you were after? Search again.

Announcements released as IMC

Date Price
sens.
Headline Pages PDF Edited
text*
22/12/2016   Immuron Files Form F-1 with the SEC 287 PDF -
09/12/2016   Appendix 3B - Issue of Options Under ESOP 12 PDF -
07/12/2016   Form 604 - Change in Substantial Shareholding (Grandlodge) 3 PDF -
02/12/2016   Appendix 3Y - Change of Director's Interest Notices (x4) 8 PDF -
02/12/2016   Appendix 3B - Issue of Rights Issue Options & ESOP Shares 12 PDF -
29/11/2016   Results of 2016 Annual General Meeting 1 PDF -
29/11/2016   2016 AGM Presentation 17 PDF -
29/11/2016 asterix Immuron Receives $1.6M R&D Tax Concession Refund 1 PDF -
28/10/2016   Notice of 2016 Annual General Meeting 20 PDF -
28/10/2016 asterix Immurons NASH Phase II Trial Achieves 100 Patient Milestone 2 PDF -
27/10/2016   Appendix 3Y - Change in Director's Interest Notice (DP) 2 PDF -
17/10/2016   Becoming a substantial holder 4 PDF -
10/10/2016 asterix NASH Phase II Trial reaches 75% of Patient Recruitment 3 PDF -
05/10/2016   NASH Assets In Demand - Allergan Acquires Tobira for US$1.7B 2 PDF -
04/10/2016   IMC - ASX - Appendix 3B (Rights Issue) 11 PDF -
04/10/2016 asterix Immurons $6M Rights Issue Closes Oversubscribed 2 PDF -
30/08/2016   Appendix 4G 10 PDF -
30/08/2016 asterix Appendix 4E and Annual Report 73 PDF -
30/08/2016 asterix Immuron Expands Collaborate with US Navy 3 PDF -
18/08/2016 asterix US NIH to Fund Second IMC Fatty Liver Study - Pediatric NASH 2 PDF -
08/08/2016 asterix Travelan to be Stocked by US Distributor Medique Products 2 PDF -
02/08/2016   Immuron to Seek Approval of Rights Issue Options at AGM 2 PDF -
20/07/2016 asterix Immuron to Cooperate with Universities on Autism Research 2 PDF -
18/07/2016 asterix Immuron to repay outstanding Convertible Note in cash 2 PDF -
15/07/2016   Form 604 -Change in Substantial Shareholding (Inverarey P/L) 4 PDF -
11/07/2016   Appendix 3Y - Change in Director's Interest Notices (x4) 8 PDF -
07/07/2016   Appendix 3B for Rights Issue & New Top 20 Shareholder List 12 PDF -
05/07/2016   Immuron Rights Issue Raises $5.33M 2 PDF -
21/06/2016 asterix IMC Signs Shigella Vaccine Developmt Agreement with US Army 3 PDF -
20/06/2016   Immuron Newsletter - June 2016 5 PDF -
16/06/2016 asterix Travelan and Protectyn Are Now Available For Sale in China 2 PDF -
14/06/2016   Immuron Extends Closing Date of $6M Rights Issue 2 PDF -
14/06/2016 asterix Travelan to Reach Upto 1.5M New US Customers via Magellans 2 PDF -
31/05/2016   Immuron Company Presentation - May 2016 43 PDF -
31/05/2016 asterix Immuron Rights Issue Offer Booklet (May 2016) 29 PDF -
31/05/2016   Letter to Ineligible Shareholders Regarding Rights Issue 3 PDF -
31/05/2016   Letter to Eligible Shareholders Regarding Rights Issue 3 PDF -
31/05/2016   Letter to Optionholders Regarding Rights Issue (May 2016) 3 PDF -
31/05/2016   Section 708AA Notice (Rights Issue) 3 PDF -
31/05/2016   Appendix 3B & 708A Notice 11 PDF -
31/05/2016 asterix Immuron Announces $6M Rights Issue Offer 4 PDF -
27/05/2016 asterix Trading halt 2 PDF -
25/05/2016 asterix NASH Phase II Trial Reaches 50% Recruitment Milestone 2 PDF -
16/05/2016   Appendix 3B & 708A Notice 11 PDF -
09/05/2016 asterix Immuron Announces E-Commerce Agreement with QBID in China 3 PDF -
28/04/2016 asterix US Distribution Reach Expanded through McKesson 2 PDF -
19/04/2016 asterix US Travelan Sales Network Widened by Allocation Inc Ptnrship 2 PDF -
18/04/2016   Appendix 3B & 708A Notice 11 PDF -
14/04/2016 asterix Expansion of US Travelan Sales Following CVS Pharmacy Launch 2 PDF -
13/04/2016   Appendix 3B - Issuance of Securities 11 PDF -
25/02/2016 asterix Appendix 4D - Half Yearly Report and Accounts 22 PDF -
24/02/2016   Appendix 3B - Issue of Securities 11 PDF -
22/02/2016 asterix Immuron Initiates Pre-Clinical Colitis Development Program 2 PDF -
17/02/2016 asterix Immuron Secures upto $1.7M Equity & Convertible Note Funding 2 PDF -
04/02/2016 asterix Immuron Receives $1.47M R&D Tax Concession Refund 1 PDF -
03/02/2016   US Analyst Reports on Immuron Products and R&D Pipeline 2 PDF -
14/01/2016 asterix Analyst Reports on Immuron IMM-529 C. difficile Program 1 PDF -
12/01/2016 asterix IMC Achieves Outstanding Results in C-Diff Recurrence Study 3 PDF -

Useful Information

Previous codes used by this company

  • ANX changed to IMC

Other companies that have used the code 'IMC'

  • INTERNATIONAL MINING CORPORATION NL - previously known as
  • INTERNATIONAL MINING CORPORATION N.L.

view available announcements for this company

Didn't find the announcement you were after? Search again.

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.